Jafron Strength
Jafron Strength

【Innovation Strength 】 Industry-leading

Jafron has great R&D capability. It is authorized by the government to set up Guangdong Engineering Research Center (ERC). Professor Xiangmei Chen, director of the PLA Institute of Nephrology Research International, is employed as Top1 biomaterial expert and Professor Yaoting Yu, is employed as Top1 Scientist of our company & ERC.

Jafron has great R&D capability. It is authorized by the government to set up Guangdong Engineering Research Center (ERC). Professor Xiangmei Chen, director of the PLA Institute of Nephrology Research International, is employed as Top1 biomaterial expert and Professor Yaoting Yu, is employed as Top1 Scientist of our company & ERC.

01.jpg

【Technical Superiority】The world's first core technology

The current disposable hemoperfusion cartridges, bilirubin adsorption columns, DNA immunoadsorption columns, hemoperfusion machines, blood purification machines and other, the main core technology for China to create the world's leading hemoperfusion, Jafron's products of nine series of more than 40 specifications, including Disposable Hemoperfusion Cartridge, Disposable Plasma Bilirubin Perfusion Adsorption Column, DNA Immunoadsorbent Column, Hemoperfusion Machine and Blood Purification Machine, with the world's first core technology of direct hemoperfusion, have been widely applied in poisoning, critical illness, kidney disease, liver disease, autoimmune diseases and other fields.

Combined artificial kidney (HD+HP, Comprehensive Clearance of Uremic Toxins)

In 2004, the concept of combined artificial kidney was first proposed

In 2016, Jafron's technology of combined artificial kidney with clinical development has covered nearly 3,500 hospitals nationwide

DPMAS: Comprehensive Solution for Severe Hepatitis

In 2016, it was brought into the Guidelines of Non-Biological Artificial Liver Treatment on Liver Failure (2016 Version)

02.jpg

【Quality Assurance】One of the first national ratified excellent group of companies passing the test of Good Manufacturing Practice of Medical Devices (GMP Inspection):    World's advanced production lines.

Jafron has passed the test of Good Manufacturing Practice (GMP) successfully. It is in the first national ratified excellent groups of companies and the second company in Guangdong Province that passed this test, also has passed CE Certification and ISO International Quality Management System Certification. Currently Jafron has production plant of 30,000 square meters and the world's most advanced hemoperfusion production lines with production plant passing GMP Test of more than 16,000 square meters and Class-10000 clean plant of over 2600 square meters which includes some Class-100 zones.

03.jpg

【Channel Advantage】Jafron's products have spread all over the country and exported to large amounts of countries and regions.

Jafron's products cover more than 30 provinces and cities of more than 3,400 large and medium-sized hospitals with market share of over 80%. What's more, Jafron's products have exported with a good sale to Turkey, Vietnam, India, Thailand, Iran, Malaysia, Bangladesh, Bulgaria, the Philippines, Sweden, Uganda and other countries and regions.

8健帆实力地图.jpg

【Talent Advantage】Talents gathering together to create a better future

Now the company totally has personnel of over 1,100 talents in management, RD, quality assurance, production, sales etc., with more than 60% coverage of college degree or above. There are 54 clinical experts who are our advanced academic consultants and 5 clinical experts who are our top academic consultants. They are all professors or doctorial tutors who are scattered in 41 big hospitals of China, working for clinical medical or teaching work for a long time.

2.jpg

Channel Advantage